Key Record Dates
ClinicalTrials.gov Identifier: | NCT02985554 |
---|---|
Brief Title: | Phase I Study to Assess the Tolerability and Efficacy of Nivolumab in Patients With Hematologic Malignancies |
First Submitted : | December 1, 2016 |
First Submitted that Met QC Criteria : | December 2, 2016 |
First Posted : | December 7, 2016 (Estimate) |
Last Update Submitted that Met QC Criteria : | June 24, 2020 |
Last Update Posted : | June 25, 2020 |